OpenFilings
Olema Pharmaceuticals, Inc.
Form
8-K
Report Period
2024-11-29
Date Filed
2024-12-02
Time Filed
07:15:09
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
8-K
EX-4.1 FORM OF PRE-FUNDED AND EXCHANGE WARRANT
EX-10.1 FORM OF SECURITIES PURCHASE AGREEMENT
EX-99.1PRESS RELEASE, DATED DECEMBER 2, 2024
Filing on SEC Edgar